The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
Background. Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed t...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2020/1283590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832568473450971136 |
---|---|
author | Charalampos Varsamas Alexandros Kalkanis Konstantinos I. Gourgoulianis Foteini Malli |
author_facet | Charalampos Varsamas Alexandros Kalkanis Konstantinos I. Gourgoulianis Foteini Malli |
author_sort | Charalampos Varsamas |
collection | DOAJ |
description | Background. Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. Methods. All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. Results. Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p<0.001, r = −0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p<0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = −0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p<0.001, r = −0.657) and polymorphonuclears percentage (p=0.02, r = −0.590), as well as days to afebrile (p=0.046, r = −0.411), duration of chest tube placement (p<0.001, r = −0.806), and days of hospitalization (p=0.013, r = −0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE. |
format | Article |
id | doaj-art-03544b0b3ace4994ad6f3a45aa931c75 |
institution | Kabale University |
issn | 1198-2241 1916-7245 |
language | English |
publishDate | 2020-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Respiratory Journal |
spelling | doaj-art-03544b0b3ace4994ad6f3a45aa931c752025-02-03T00:58:52ZengWileyCanadian Respiratory Journal1198-22411916-72452020-01-01202010.1155/2020/12835901283590The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural EffusionsCharalampos Varsamas0Alexandros Kalkanis1Konstantinos I. Gourgoulianis2Foteini Malli3Respiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, GreeceLouvain University Center for Sleep and Wake Disorders, Leuven, BelgiumRespiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, GreeceRespiratory Medicine Department, University of Thessaly, School of Medicine, Larissa, GreeceBackground. Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. Methods. All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. Results. Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p<0.001, r = −0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p<0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = −0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p<0.001, r = −0.657) and polymorphonuclears percentage (p=0.02, r = −0.590), as well as days to afebrile (p=0.046, r = −0.411), duration of chest tube placement (p<0.001, r = −0.806), and days of hospitalization (p=0.013, r = −0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE.http://dx.doi.org/10.1155/2020/1283590 |
spellingShingle | Charalampos Varsamas Alexandros Kalkanis Konstantinos I. Gourgoulianis Foteini Malli The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions Canadian Respiratory Journal |
title | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_full | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_fullStr | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_full_unstemmed | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_short | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_sort | use of a novel quantitative marker of echogenicity of pleural fluid in parapneumonic pleural effusions |
url | http://dx.doi.org/10.1155/2020/1283590 |
work_keys_str_mv | AT charalamposvarsamas theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT alexandroskalkanis theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT konstantinosigourgoulianis theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT foteinimalli theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT charalamposvarsamas useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT alexandroskalkanis useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT konstantinosigourgoulianis useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT foteinimalli useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions |